🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced

Recruitingn/aAges 18 Years - anyAllMSD Italia S.r.l.
NCT06467383 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is a non-interventional, retrospective observational study to improve knowledge regarding the diagnosis and treatments of patients who have/had non-small cell lung cancer (NSCLC), either early stage (stage I-II).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Patients with stage I-III NSCLC who have received curative surgery or radiotherapy between January 2018 and June 2019 with available follow-up through January 2021 2. Adult patients (aged ≥ 18 years) at the moment of diagnosis 3. Patients (or their legally acceptable representatives) must have signed and dated the Informed Consent form; privacy Form (ICF). In case of deceased or untraceable patient the investigator before collecting data shall demonstrate and report all necessary measures adopted to contact the patient. Exclusion Criteria: 1. Patients without availability of medical charts or information required 2. Enrollment in studies imposing a specific patient's management strategy which does not correspond to the site's normal clinical practice.
💊

What it tests

  • Not listed
📍

Where

25 sites
IRCCS Casa di sollievo dalla sofferenza
San Giovanni Rotondo, Italy
ASST degli Spedali Civili di Brescia
Brescia, Italy
Gemelli Molise
Campobasso, Italy
Humanitas Istituto Clinico Catanese
Catania, Italy
Policlinico Rodolico
Catania, Italy
AOU Careggi
Florence, Italy
IRCCS Policlinico S. Martino
Genova, Italy
AO Papardo
Messina, Italy

…and 17 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy